Hypophosphataemia and osteomalacia in haemodialysis patients not taking phosphate binders.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D001842:Bone and Bones / Q000473:pathology; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D004097:Dihydrotachysterol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000097:blood; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D010018:Osteomalacia / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood* / Q000378:metabolism; D006435:Renal Dialysis
D010281:Parathyroid Hormone; D010710:Phosphates; D000536:Aluminum Hydroxide; D000469:Alkaline Phosphatase; D004097:Dihydrotachysterol; D006909:Hydroxyproline